Worldwide revenue from the recombinant cell culture supplements market reached a valuation of around US$ 495.5 Mn at the end of 2022, with the global market forecasted to surge ahead at a CAGR of 6.0% to reach a valuation of US$ 947.7 Mn by the end of 2033.
The global market for recombinant cell culture supplements recorded a historic CAGR of 5.8% in the last 8 years from 2014 to 2022. Overall, recombinant cell culture supplements sales accounted for 16.5% of the US$ 3.0 Bn global cell culture media market in 2022.
Request For Free Sample Report of “Recombinant Cell Culture Supplements Market”@ https://www.persistencemarketresearch.com/samples/31310
These days, a majority of supplements used in research and manufacturing are produced using recombinant technology. Recombinant supplements play an important role in gene and cell therapy. Cell therapy requires to grow the cells outside the human body, i.e. in-vitro, and, recombinant cell culture supplements are inevitable for such applications. Due to rapid development within the biopharmaceutical industry, recombinant cell culture supplements are anticipated to witness significant demand through 2031.
According to a latest report published by Persistence Market Research, the global recombinant cell culture supplements market was valued at US$ 441 Mn in 2020, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2021 – 2031).
Key Takeaways from Recombinant Cell Culture Supplements Market Study
- Recombinant growth factors are expected to contribute more than 1/3 of the revenue share in the market.
- By end user, biopharmaceutical companies will hold a major share of over 40% of the market. This sector is the most advancing as compared to other end users.
- By application, stem cell therapy is expected to hold the highest market share in 2020.
- North America holds over 1/3 of the global recombinant cell culture supplements market share.
- Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
- The COVID-19 outbreak created a surge in demand for recombinant cell culture supplements, thus, accelerating growth of the market in 2020. Recombinant cell culture supplements were widely used in stem cell research and other cell-based assays performed for COVID-19 research.
- The market in China is projected to be the fastest-growing, and will expand at a CAGR above 9% through 2031.
- The U.S. market holds a big portion of the market revenue and accounts for more than 90% in North America.
- The market in the U.K. is expected to expand at a CAGR of around 7%, while that in China is pegged at over 9%.
“Increasing drug discovery and preference for recombinant technology for bio- production will upswing the global recombinant cell culture supplements market,” says an analyst of Persistence Market Research.
Buy Full Report Now@ https://www.persistencemarketresearch.com/checkout/31310
Collaborations & Acquisitions Key Strategies amongst Market Players
Prominent players in the recombinant cell culture supplements market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour the growth the global market over the forecast period
For instance, Cytiva (part of GE company), in 2018, announced the increase of its yearly production capacity of cell culture supplements and media.
In July 2019, FUJIFILM Irvine Scientific announced the expansion of a new cell culture media manufacturing facility in Europe. FUJIFILM Irvine Scientific has already over 3 production facilities in the bio production sector, and gene and cell therapy.
Various players in the recombinant cell culture supplements market are focusing on growth strategies such as acquisitions and collaborations.
One of the major acquisitions in the biopharmaceutical industry happened in 2015, when Merck KGaA acquired Sigma-Aldrich to strengthen and expand its cell culture product range.
Thermo Fisher Scientific, in March 2020, signed an agreement with Janssen to co-develop novel cancer diagnostics.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the recombinant cell culture supplements market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, on the basis of product (recombinant growth factors, recombinant insulin, recombinant albumin, recombinant transferrin, recombinant trypsin, recombinant aprotinin, recombinant lysozyme, and others), application (stem cell therapy, gene therapy, bioprocess application, vaccine development, and others), source (animals, microorganisms, and humans), and end user (academic and research institutes, biopharmaceutical companies, cancer research centers, and contract research centers (CROs)), across seven key regions of the world.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/31310
Segments of Recombinant Cell Culture Supplements Industry Research
By Product:
- Recombinant Growth Factors
- Transforming Growth Factor
- Epidermal Growth Factor
- Platelet-Derived Growth Factors
- Fibroblast Growth Factor
- Vascular Endothelial Growth Factors (VEGFs)
- Interleukins
- Recombinant Stem Cell Factor
- Other Growth Factors
- Recombinant Insulin
- Recombinant Albumin
- Recombinant Transferrin
- Recombinant Trypsin
- Recombinant Aprotinin
- Recombinant Lysozyme
- Others
By Application:
- Stem Cell Therapy
- Gene Therapy
- Bioprocess Application
- Vaccine Development
- Others
By Source:
- Animals
- Microorganisms
- Human
By End User:
- Academic and Research Institutes
- Biopharmaceutical Companies
- Cancer Research Centers
- Contract Research Centers (CROs)
For More Premium Insights, Check out the Link:
Macular Degeneration Treatment Market
Automated Suturing Devices Market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
